Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PSA screening--current controversy

D Svetec1, I M Thompson

  • 1Department of Surgery, Brooke Army Medical Center, University of Texas Health Sciences Center, San Antonio, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|February 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply by Authors.

The Journal of urology·2020
Same author

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Association of dry matter intake and energy balance prepartum and postpartum with health disorders postpartum: Part II. Ketosis and clinical mastitis.

Journal of dairy science·2019
Same author

Association of dry matter intake and energy balance prepartum and postpartum with health disorders postpartum: Part I. Calving disorders and metritis.

Journal of dairy science·2019
Same author

Effect of the concentration of circulating prolactin on dairy cows' responsiveness to domperidone injection.

Journal of dairy science·2018
Same author

Effect of 17β-estradiol on milk production, hormone secretion, and mammary gland gene expression in dairy cows.

Journal of dairy science·2017
Same journal

The ethical obligation to use positive trial results.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Lorlatinib: The Crown Jewel of ALK Inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same journal

Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
See all related articles

Prostate-Specific Antigen (PSA) screening for prostate cancer remains controversial due to limited clinical trial data. This review addresses key questions surrounding PSA screening to provide clarity on this contentious urological issue.

Area of Science:

  • Urology
  • Oncology
  • Medical Screening

Background:

  • Prostate cancer screening using Prostate-Specific Antigen (PSA) is a highly debated topic in urology.
  • Current recommendations are complicated by the absence of definitive randomized clinical trials.
  • Conflicting interpretations of available clinical data lead to disagreements among various stakeholders.

Purpose of the Study:

  • To address the contentious issue of Prostate-Specific Antigen (PSA) screening for prostate cancer.
  • To provide perspective on PSA screening by answering a series of critical questions.
  • To synthesize existing medical literature in the absence of completed randomized clinical trials.

Main Methods:

  • Review of extrapolated clinical data from the medical literature.

Related Experiment Videos

  • Analysis of arguments and counterarguments regarding PSA screening.
  • Structured discussion addressing five key questions pertinent to PSA screening.

    • Main Results:

    • The application and efficacy of PSA screening are subject to varied interpretations.
    • Disagreements exist among patient groups, governmental agencies, medical organizations, and managed care providers.
    • The lack of completed randomized trials contributes to the ongoing debate.

    Conclusions:

    • The optimal use of PSA screening for prostate cancer requires careful consideration of available, albeit often conflicting, data.
    • Further research and consensus-building are needed to guide clinical practice.
    • Understanding the nuances of PSA screening is crucial for urological decision-making.